NasdaqGS - Delayed Quote • USD
Embecta Corp. (EMBC)
At close: May 17 at 4:00 PM EDT
After hours: May 17 at 6:29 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 4 | 4 |
| Avg. Estimate | 0.46 | 0.53 | 2.27 | 2.26 |
| Low Estimate | 0.41 | 0.5 | 2.25 | 2.07 |
| High Estimate | 0.51 | 0.56 | 2.35 | 2.4 |
| Year Ago EPS | 0.69 | 0.59 | 2.99 | 2.27 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 3 | 3 | 4 | 4 |
| Avg. Estimate | 267.58M | 281.68M | 1.12B | 1.12B |
| Low Estimate | 266M | 280.9M | 1.11B | 1.11B |
| High Estimate | 268.9M | 283M | 1.12B | 1.13B |
| Year Ago Sales | -- | 281.9M | 1.12B | 1.12B |
| Sales Growth (year/est) | -- | -0.10% | -0.50% | 0.40% |
Earnings History
| CURRENCY IN USD | 6/30/2023 | 9/30/2023 | 12/31/2023 | 3/31/2024 |
|---|---|---|---|---|
| EPS Est. | 0.46 | 0.4 | 0.45 | 0.4 |
| EPS Actual | 0.69 | 0.59 | 0.61 | 0.67 |
| Difference | 0.23 | 0.19 | 0.16 | 0.27 |
| Surprise % | 50.00% | 47.50% | 35.60% | 67.50% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0.46 | 0.53 | 2.27 | 2.26 |
| 7 Days Ago | 0.52 | 0.51 | 2.17 | 2.2 |
| 30 Days Ago | 0.55 | 0.53 | 2.1 | 2.21 |
| 60 Days Ago | 0.55 | 0.53 | 2.1 | 2.21 |
| 90 Days Ago | 0.55 | 0.53 | 2.1 | 2.21 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | 1 | 1 | 2 |
| Up Last 30 Days | -- | 2 | 4 | 3 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | 1 | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | EMBC | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -33.30% | -- | -- | 8.00% |
| Next Qtr. | -10.20% | -- | -- | 12.40% |
| Current Year | -24.10% | -- | -- | 5.60% |
| Next Year | -0.40% | -- | -- | 13.00% |
| Next 5 Years (per annum) | -- | -- | -- | 11.14% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Maintains | Morgan Stanley: Underweight to Underweight | 5/10/2024 |
| Maintains | Morgan Stanley: Underweight to Underweight | 11/22/2023 |
| Maintains | Morgan Stanley: Underweight to Underweight | 10/18/2023 |
| Maintains | Morgan Stanley: Underweight to Underweight | 8/24/2023 |
| Maintains | Morgan Stanley: Underweight to Underweight | 7/18/2023 |
| Maintains | Morgan Stanley: Underweight to Underweight | 5/15/2023 |
Related Tickers
BDX Becton, Dickinson and Company
236.30
-0.14%
BAX Baxter International Inc.
35.25
+0.23%
ATRC AtriCure, Inc.
23.14
+2.25%
WRBY Warby Parker Inc.
16.53
+2.42%
COO The Cooper Companies, Inc.
97.31
-0.60%
NVST Envista Holdings Corporation
18.53
-3.14%
TFX Teleflex Incorporated
217.64
-0.43%
UTMD Utah Medical Products, Inc.
69.72
-1.04%
ANIK Anika Therapeutics, Inc.
25.40
-0.39%
SRT.DE Sartorius Aktiengesellschaft
214.00
-2.73%